chemical hazard Recalls

B Braun Medical Extension Set Recall for IV Pumps Recalled Worldwide Over Backflow and Occlusion Haz

Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).

Siluetaya Tejocote Root Herbal Supplement Recall 40 Online Bottles Over Yellow Oleander (2025)

B Braun Medical Recalls 12,168 IV Administration Sets for Backflow and Occlusion Risk (2025)

Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).

B Braun Vista IV Set Recall for 74,652 Units Over Backflow and Occlusion Risk

Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).

B. Braun Medical Recalls 32,500 Caresite Extension Sets for IV Pumps (2025)

Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).

B Braun Medical Extension Set Recalled for 1,200 Units Over Backflow and Occlusion Risk (2025 Recall

Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).

B Braun Medical 490202 Extension Set Recall: 13,600 Units Over Backflow Risk (2025)

Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).

B. Braun Medical Extension Set Recall Covers 300 Units for Backflow, Occlusion Risk (2025)

Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).

B Braun Medical ADDitIV Sets Recalled for High Backflow and Occlusion Risk, 43,900 Units Worldwide

Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).

BBraun Medical Inc. Recalled 104,784 Anesthesia IV Sets Over Backflow, Occlusion Risk

Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).

B Braun Medical IV Set Recall Affects 32,436 Units Over Backflow and Occlusion Risks (2025)

Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).

B Braun Medical Inc. Recalls 28,344 IV Administration Sets Linked to Backflow and Occlusion Risks (Z

Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).

B Braun Medical IV Administration Sets Recalled Over Backflow and Occlusion Risk (2025)

Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).

B. Braun Medical Recalls 7,008 IV Administration Sets for Infusomat Space Pumps (2025)

Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).

B Braun Medical IV Administration Set Recall Affects 2,544 Units Worldwide

Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).

B. Braun Medical Recalls 12,700 ADDitIV Gravity IV Sets Over Backflow Risk (2025)

Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).

B Braun Medical IV Administration Set Recall: 5,100 Units Distributed Worldwide Over Backflow and Oc

Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).

BBMI IV Administration Sets Recalled in 2025 for Backflow and Occlusion Risk, 20.7 Million Units

Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).

BBraun Medical IV Administration Set Recalled for Backflow and Occlusion Risk (490491, 2025)

Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).

B. Braun Medical Recalled 12,225,913 CARESITE IV Sets for Backflow, Occlusion (2025)

Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).